Editorial: What Can be Learned from National and International Vaccine Adverse Event Reporting Systems During the COVID-19 Pandemic?

Posted: 2021-11-01 19:00:00
Healthcare professionals have an ethical, medico-legal, and professional responsibility to report all suspected adverse events following immunization to relevant national reporting agencies as part of the process of post-marketing drug safety monitoring. In the US, the Vaccine Adverse Event Reporting System (VAERS) is co-sponsored by the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). Data from VAERS and other national and global reporting systems show very low rates of adverse events related to currently approved SARS-CoV-2 vaccines. Populations studies have supported the findings from adverse event reporting systems. The presentation, monitoring, and reporting of adverse events related to SARS-CoV-2 vaccines may have future applications in vaccine monitoring for several other potential pandemic zoonotic infections. This editorial aims to summarize the current understanding of adverse events from current COVID-19 vaccines from global adverse event reporting systems, rather than individual case reports or anecdotal reporting in the media.

参考サイト PubMed: covid-19

Powered by Vergleichsportal


5月 20, 2020 バイオアソシエイツ


2020年5月8日にCMAJ(Canadian Medical Association Journal)でオンライン公開された多国間の調査によると、気温と緯度は新型コロナウイルス( COVID-19 )の蔓延とは関連していないようだ。しかし学校の閉鎖やその他の公衆衛生対策がプラスの効果をもたらしているという。 この論文は「COVID-19パンデミックに対する気候と公衆衛生の介入の影響:前向きコホート研究(Impact of climate and public health interventions on…

ゲスト 925人 と メンバー 4人 がオンラインです